Definitive Healthcare (DH) Expected to Announce Quarterly Earnings on Thursday

Definitive Healthcare (NASDAQ:DH) is expected to be issuing its Q1 2026 results after the market closes on Thursday, May 7th. Analysts expect the company to announce earnings of $0.03 per share and revenue of $55.0210 million for the quarter. Parties are encouraged to explore the company’s upcoming Q1 2026 earning overview page for the latest details on the call scheduled for Thursday, May 7, 2026 at 5:00 PM ET.

Definitive Healthcare Price Performance

Shares of NASDAQ:DH traded down $0.07 during trading on Tuesday, reaching $0.96. The stock had a trading volume of 390,697 shares, compared to its average volume of 354,960. Definitive Healthcare has a 52 week low of $0.90 and a 52 week high of $4.70. The business’s 50-day moving average price is $1.12 and its 200 day moving average price is $2.02. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.64 and a quick ratio of 1.64. The stock has a market capitalization of $101.48 million, a PE ratio of -0.77, a P/E/G ratio of 86.21 and a beta of 1.34.

Institutional Trading of Definitive Healthcare

A number of institutional investors have recently bought and sold shares of DH. Raymond James Financial Inc. acquired a new stake in Definitive Healthcare during the 2nd quarter worth $32,000. Schonfeld Strategic Advisors LLC acquired a new stake in Definitive Healthcare during the 4th quarter worth $35,000. HRT Financial LP acquired a new stake in Definitive Healthcare during the 4th quarter worth $47,000. ExodusPoint Capital Management LP acquired a new stake in Definitive Healthcare during the 4th quarter worth $47,000. Finally, Bayesian Capital Management LP acquired a new stake in Definitive Healthcare during the 2nd quarter worth $55,000. Institutional investors and hedge funds own 98.67% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on the stock. Stephens lowered their price target on shares of Definitive Healthcare from $3.00 to $2.00 and set an “equal weight” rating for the company in a report on Friday, February 27th. Wall Street Zen raised shares of Definitive Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, March 14th. Weiss Ratings reissued a “sell (d-)” rating on shares of Definitive Healthcare in a report on Wednesday, January 21st. Zacks Research raised shares of Definitive Healthcare from a “strong sell” rating to a “hold” rating in a report on Tuesday, April 28th. Finally, Canaccord Genuity Group lowered their price target on shares of Definitive Healthcare from $4.00 to $3.00 and set a “hold” rating for the company in a report on Friday, February 27th. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, five have assigned a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $3.27.

About Definitive Healthcare

Definitive Healthcare (NASDAQ:DH) is a leading provider of intelligence and analytics on healthcare providers, organizations and the professionals who treat patients. Through its cloud-based platform, the company aggregates data from multiple sources—including claims, government registries, commercial filings and proprietary research—to deliver a unified view of the healthcare landscape. Its solutions enable life sciences companies, healthcare providers, payers and consulting firms to identify market opportunities, optimize sales and marketing efforts, improve operational efficiency and support better patient outcomes.

The company’s flagship offering is a subscription-based data platform that features detailed profiles on physicians, hospitals, health systems and post-acute care facilities.